Chemed Reports Third-Quarter 2026 Results
Key Highlights
- ➤Q3 revenue $690.9 million, up 10.6% year over year
- ➤Adjusted diluted EPS $6.75, up 28.1% year over year
- ➤VITAS adjusted EBITDA $92.5 million, up 31.4%; margin reached 20.2%
- ➤Roto-Rooter adjusted EBITDA $48.2 million, down 2.5%; margin fell 213 basis points
- ➤Chemed expects full-year 2026 adjusted EPS at or slightly above guidance high-end
- ➤Roto-Rooter re-acquired California franchise territories for approximately $62.5 million
CINCINNATI, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2026, versus the comparable prior-year period.
Consolidated operating results: * Revenue increased 10.6% to $690.9 million * GAAP Diluted Earnings-per-Share (EPS) of $5.45, an increase of 22.2% * Adjusted Diluted EPS of $6.75, an increase of 28.1% VITAS segment operating results: * Net Patient Revenue of $457.4 million, an increase of 12.2% * Average Daily Census (ADC) of 24,428, an increase of 9.4% * Admissions of 18,995, an increase of 7.2% * Net Income, excluding certain discrete items, of $70.8 million, an increase of 44.7% * Adjusted EBITDA, excluding Medicare Cap, of $92.5 million, an increase of 31.4% * Adjusted EBITDA margin, excluding Medicare Cap, of 20.2%, an increase of 318-basis points Roto-Rooter segment operating results: * Revenue of $233.5 million, an increase of 7.5% * Net Income, excluding certain discrete items, of $33.3 million, a decline of 1.8% * Adjusted EBITDA of $48.2 million, a decline of 2.5% * Adjusted EBITDA margin of 20.6%, a decline of 213-basis points VITAS
Get started
Create a free account to read the full story.